Hisashi Saji

12PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 27, 2026
Surgical Complexity and Perioperative Feasibility Following Neoadjuvant Chemotherapy, Chemoradiotherapy, or Chemoimmunotherapy in Stage II-III Non-Small Cell Lung Cancer: A Retrospective Single-Institution Study.

|Jul 19, 2026
Adenoid cystic carcinoma of the thymus: a case report and literature review.

|Jun 22, 2025
Anatomical segmentectomy versus wedge resection for small (≤2 cm) peripheral non-small cell lung cancer in 80 or more aged elderly patients: a randomized phase III study (JCOG2109, AWESOME).

Takahiro Mimae, Masashi Wakabayashi, Yusuke Sano

|Nov 23, 2021
Solid histological component of adenocarcinoma might play an important role in PD-L1 expression of lung adenocarcinoma.

Tomoyuki Miyazawa, Kei Morikawa, Kanji Otsubo

|Oct 16, 2021
Thoracic mesenchymal malignant tumors and programed cell death ligand-1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas.

Kanji Otsubo, Hiroki Sakai, Hiroyuki Kimura

|Aug 13, 2021
Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer.

Tomoyuki Miyazawa, Kanji Otsubo, Hiroki Sakai

Pageof 2

Frequent Collaborators

5 joint publications

Naoki Furuya

3 joint publications

Masamichi Mineshita

3 joint publications

Takahiro Homma

2 joint publications

Tomoyuki Miyazawa